¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"osteoid substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • spongy substance
    °¹¼ØÁú, ÇØ¸éÁú
  • substance
    ¹°Áú
  • substance P
    ¼­ºê½ºÅĽºP, ¹°ÁúP
  • substance withdrawal
    ¹°Áú±Ý´Ü
  • slow-reacting substance
    Áö¿¬¹ÝÀÀ¹°Áú
  • visual substance
    ½Ã°¢¹°Áú
  • volatile substance
    Èֹ߹°Áú
  • white substance
    ¹é(»ö)Áú
  • zymoplastic substance
    ÀÀÇ÷ÃËÁø¹°Áú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • fundamental substance
    ¹«ÇüÁú
  • gap substance
    »çÀ̹°Áú
  • gelatinous substance
    ¾Æ±³Áú
  • goitrogenic substance
    ¹æÆÐ»ùÁ¾À¯¹ß¹°Áú, °©»ó»ùÁ¾À¯¹ß¹°Áú
  • gray substance
    ȸ»öÁú
  • ground substance
    ¹ÙÅÁÁú
  • heparinoid substance
    ÇìÆÄ¸°¼º¹°Áú
  • heterogeneous substance
    ºÒ±ÕÁúü
  • horny substance
    °¢Áú
  • inducer substance
    À¯µµ¹°Áú
  • inhibitor substance
    ¾ïÁ¦¹°Áú
  • intercellular substance
    ¼¼Æ÷»çÀ̹°Áú
  • intercellular cement substance
    ¼¼Æ÷»çÀ̰áÇÕ¹°Áú
  • interference substance
    °£¼·¹°Áú
  • ketogenic substance
    ÄÉÅæÃ¼Çü¼º¹°Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • heterogeneous substance
    ºÒ±ÕÁúü.
  • horny substance
    °¢Áú(ÊÇòõ).
  • pneumococcal C-substance
    Æó·Å±¸±Õ C-¹°Áú
  • postacrosomal substance
    ÷´ÜüµÚ¹°Áú
  • posterior perforated substance
    µÚ°üÅëÁú
  • posterior perforated substance ³ª substantia perforata posterior
    ÈÄÀ¯°øÁú(ý­êóÍîòõ).
  • posterior perforated substance ³ª substantia perforata posterior
    ÈÄÀ¯°øÁú(ý­êóÍîòõ).
  • pressor substance
    Ç÷¾Ð»ó½Â¹°Áú(¡­Úªòõ).
  • proper substance of cornea
    °¢¸·°íÀ¯Áú
  • proper substance of sclera
    °ø¸·°íÀ¯Áú
  • pyrogenic substance
    ¹ß¿­¹°Áú, ¹ß¿­ÀÎÀÚ.
  • pyrogenic substance
    ¹ß¿­¹°Áú(Û¡æðÚªòõ), ¹ß¿­ÀÎÀÚ(Û¡æðì×í­)
  • radiomimetic substance
    ¹æ»ç¼± À¯»çÀÛ¿ë¹°Áú
  • reaction substance
    ¹ÝÀÀ¹°Áú(ÚãëëÚªòõ).
  • red green visual substance
    Àû·Ï(»ö)½Ã°¢ ¹°Áú.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • blood substance
    Ç÷¾× ´ë¿ëÁ¦(úìäûÓÛéÄð¥)
  • bone substance
    °ñ Áú(Íéòõ).
  • carcinogen =carcinogenic substance
    ¹ß¾Ï(¼º)¹°Áú(Û¡ç÷àõÚªòõ).[¾à¸®] ¹ß¾Ï¹°Áú<¿ø>, ¹ß¾Ï¼º(Û¡äßàõ).
  • carcinogen =carcinogenic substance
    ¹ß¾Ï(¼º)¹°Áú(ËÑËçËÛËÑ̤).¾à¸® ¹ß¾Ï¹°Áú<¿ø>, ¹ß¾Ï¼º(ËÑËâËÛ).
  • cement substance
    Á¢ÇÕÁú(ïÈùêòõ).
  • central gelatinous substance
    Á߽ɾƱ³Áú
  • central gray (substance)
    Áß½Éȸ»öÁú
  • central intermediate substance
    Áß½ÉÁß°£È¸»öÁú
  • chromophilic substance nissl body
    ´Ö½½¼Òü
  • compact substance
    Ä¡¹Ð¹°Áú, Ä¡¹ÐÁú (öÆÚËòõ).
  • cortical substance
    ÇÇ(Áú¹°)Áú.
  • cortical substance
    »À°ÑÁú
  • crystalline substance
    °áÁ¤¹°Áú.
  • cytotoxic substance =cytotoxin
    µ¶(¼Ò)(á¬øàÔ¸áÈ).
  • depressor substance
    °¨¾Ð¹°Áú(¡­Úªòõ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Substance of synaptic cleft
    Æ´»õ¹°Áú
    [¿¾ ¿ë¾î] ¿­³»Áú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ams amount of a substance
ANAS anastomosis; auditory nerve activating substance
AS acetylstrophanthidin; acidified serum; acoustic schwannoma; acoustic stimulation; active sarcoidosis...
ASSERT improving Alcohol and Substance abuse Services and Educating providings to Refer patients to Treatme...
BGS balance, gait, and station; blood group substance; British Geriatrics Society
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MIS Muellerian inhibiting substance
PSUD Psychoactive Substance Use Disorder
"RCS" Rabbit aorta Contracting Substance
SRS-A Slow Reacting Substance of Anaphylaxis
SRS Slow reacting substance
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • slow-reating substance
    Áö¹ÝÀÀ¼º ¹°Áú
    ¾î¶² ÆòȰ±ÙÀÇ ´À¸®°í Áö¼Ó¼ºÀÎ ¼öÃàÀ» ÀÏÀ¸Å°´Â ¾Æ³ªÇʶô½Ã ¹ÝÀÀ ½Ã¿¡ ¹æÃâµÇ´Â ¹°Áú ±âÈ£ SRS-A.
  • substance defect
    ¹°Áú °áÇÌ
  • substance P fiber
    P ¹°Áú ¼¶À¯
  • toxic substance
    À¯µ¶ ¼ººÐ, µ¶¹°
  • transmitter substance
    Àü´Þ ¹°Áú
  • white substance
    ¹é»ö Áú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
muscular substance of prostate The smooth muscle in the stroma of the prostate.
Synonym: substantia muscularis prostatae, musculus prostaticus.
(05 Mar 2000)
controlled substance A substance subject to the Controlled Substances Act (1970), which regulates the prescribing and dispensing, as well as the manufacturing, storage, sale, or distribution of substance's assigned to five schedules according to their 1) potential for or evidence of abuse, 2) potential for psychic or physiologic dependence, 3) contributing a public health risk, 4) harmful pharmacologic effect, or 5) role as a precursor of other controlled substance's.
(05 Mar 2000)
cortical substance The superficial thin layer of compact bone.
Synonym: substantia corticalis, cortical substance.
(05 Mar 2000)
posterior perforated substance The bottom of the interpeduncular fossa at the base of the midbrain, extending from the anterior border of the pons forward to the mamillary bodies, and containing numerous openings for the passage of perforating branches of the posterior cerebral arteries.
Synonym: substantia perforata posterior, locus perforatus posticus, Malacarne's space.
(05 Mar 2000)
pressor substance One of several products of intestinal putrefaction believed to cause functional hypertension when absorbed, any alkaline substance that raises blood pressure.
Synonym: pressor amine, pressor substance.
(05 Mar 2000)
proper substance See: substantia propria of cornea, substantia propria membranae tympani, substantia propria sclerae.
(05 Mar 2000)
schwann's white substance <anatomy> The substance of the medullary sheath.
Source: Websters Dictionary
(01 Mar 1998)
psychoses, substance-induced Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
(12 Dec 1998)
sensitizing substance Antibody that combines with and sensitises antigen leading to the activation of complement, which may result in cell lysis.
Synonym: CF antibody, sensitizing substance.
(05 Mar 2000)
h substance <haematology> A polysaccharide precursor molecule which is used to make the antigens on the surface of human blood cells that are classified in the ABO blood group system.
(09 Oct 1997)
slow-reacting substance Slow-reacting substance of anaphylaxis (SRS-A), a leukotriene of low molecular weight which is released in anaphylactic shock and produces slower and more prolonged contraction of muscle than does histamine; it is active in the presence of antihistamines (but not epinephrine) and seems not to occur preformed in mast cells, but as a result of an antigen-antibody reaction on the granules.
Compare: peptidyl leukotrienes.
Synonym: slow-reacting factor of anaphylaxis.
(05 Mar 2000)
slow reacting substance of anaphylaxis <immunology> Potent bronchoconstrictor and inflammatory agent released by mast cells, an important mediator of allergic bronchial asthma.
A mixture of three leukotrienes (LTC4 mainly, LTD4 and LTE4)
(18 Nov 1997)
soluble specific substance A soluble type-specific polysaccharide produced during active growth of virulent pneumococci composing a large part of the capsule.
Synonym: pneumococcal polysaccharide, soluble specific substance, specific soluble polysaccharide, specific soluble sugar.
(05 Mar 2000)
specific capsular substance A soluble type-specific polysaccharide produced during active growth of virulent pneumococci composing a large part of the capsule.
Synonym: pneumococcal polysaccharide, soluble specific substance, specific soluble polysaccharide, specific soluble sugar.
(05 Mar 2000)
spongy substance Bone in which the spicules or trabeculae form a three-dimensional latticework (cancellus) with the interstices filled with embryonal connective tissue or bone marrow.
Synonym: substantia trabecularis, cancellous bone, spongy bone, spongy substance, trabecular bone.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á